Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
about
Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer riskMT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer.Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Matrix metalloproteinase-9 in lung remodeling.ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cellsEmerging drugs for non-small cell lung cancer.Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.Hypercoagulability and lung cancer.Current concepts on the role of inflammation in COPD and lung cancer.The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer.Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model.Menadione : sodium orthovanadate combination eliminates and inhibits migration of detached cancer cellsBlockade of the sympathetic nervous system degrades ligament in a rat MCL model.The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.Expression profiling of primary non-small cell lung cancer for target identification
P2860
Q26771838-556A282B-9C25-426B-AB6B-547620941410Q33898816-F5D7B698-7993-43CE-8A31-4C47F5CF6A8AQ34293732-8402D66B-BEFC-45E0-B646-E47BC9BF191EQ35032152-CAC942FB-0CFD-4121-A61A-85E3F64C3877Q35140315-712ABA8A-240B-4A25-8557-7A13502E2220Q35581167-5B734715-08AC-47EF-BF29-64724C83800AQ35680985-7F1A5B57-8BCF-4FD6-A06A-E4F16371D6ABQ37188554-56F51AD6-7285-4622-8660-7FD860C4779BQ37316084-12E95401-2953-4B79-8AC5-FE5D95259BB1Q37839576-FE846C5E-408F-43C1-B87B-0875B4F4B5D0Q38865803-D4F9D664-0A57-4920-959F-80D8D622D985Q40397931-EC93AEEB-714E-46CD-84CB-FA89C67E11F5Q41957492-842E1981-59D0-48C2-8F31-40991F867CB8Q44607685-661766F5-0D4B-43F8-BACD-ABC455DF09D9Q53655377-6B9AF35B-041B-4D9B-A111-92295E8E1990Q58068682-C1F14D0A-4AE5-4CE6-B880-BE514ACD34F2
P2860
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@ast
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@en
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@nl
type
label
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@ast
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@en
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@nl
prefLabel
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@ast
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@en
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@nl
P356
P1433
P1476
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
@en
P2093
Philip Bonomi
P356
10.1053/SONC.2002.31528
P433
P577
2002-02-01T00:00:00Z